e-learning
resources
Paris 2018
Monday, 17.09.2018
Clinical determinants and biomarkers of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Monitoring antioxidant enzyme activity in patients with COPD exacerbations
B. Antus (Budapest, Hungary), C. Paska (Budapest, Hungary), I. Barta (Budapest, Hungary)
Source:
International Congress 2018 – Clinical determinants and biomarkers of COPD
Session:
Clinical determinants and biomarkers of COPD
Session type:
Poster Discussion
Number:
2010
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Antus (Budapest, Hungary), C. Paska (Budapest, Hungary), I. Barta (Budapest, Hungary). Monitoring antioxidant enzyme activity in patients with COPD exacerbations. 2010
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Simultaneous assessment of DNA damage and antioxidant enzyme activity in COPD exacerbations
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
Monitoring catalase activity in COPD exacerbations
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Role of antioxidant in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 249s
Year: 2001
Physical activity and exercise capacity in patients with moderate COPD exacerbations
Source: Eur Respir J 2016; 48: 340-349
Year: 2016
The effects of physical activity coaching in patients with COPD after an acute exacerbation
Source: International Congress 2014 – Exercise training and physical activity in patients with COPD
Year: 2014
Changes in antioxidant enzyme levels in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury
Year: 2009
Physical activity determinants in COPD patients in the community
Source: International Congress 2016 – Best abstracts in physical activity and telemedicine
Year: 2016
Antioxidant defence in acute exacerbation of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 249s
Year: 2001
Change in physical activity level following COPD exacerbation
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015
Physical activity and the use of COPD medication
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015
Decrease of physical activity in patients with COPD in the course of the disease
Source: Annual Congress 2012 - The best abstracts in chronic care
Year: 2012
Assessment of malondialdehyde in the airways during treatment of COPD exacerbations
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Erdosteine improves airflow in patients with severe exacerbation of COPD (AECOPD)
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
The dynamics of blood plasma antioxidant activity in patients with asthma exacerbation during the course of Phosphogliv admission
Source: Eur Respir J 2007; 30: Suppl. 51, 616s
Year: 2007
Paraoxonase activity in patients with COPD
Source: Annual Congress 2011 - Novel mechanisms in lung injury
Year: 2011
Monitoring oxidative stress in the lung: Changes in superoxide dismutase (SOD) activity during the course of acute exacerbations in COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Inflammation markers and antioxidant activity in patients with bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 217s
Year: 2001
Effect of physical inactivity on COPD exacerbations
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Metabolic and inflammatory profile in patients with COPD and physical activity.
Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD
Year: 2021
Physical activity during and after a severe acute exacerbation of COPD
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept